申请人:SCHERING CORPORATION
公开号:EP0508792A1
公开(公告)日:1992-10-14
Compounds of formula:
or pharmaceutically acceptable salts thereof wherein X, Y, R1, R2, R3, R4, R5, and R6, are as set forth herein are described. These compounds are useful as anti-tumor agents. These compounds are also useful as anti-psoriatic agents.
式的化合物:
或其药学上可接受的盐类,其中 X、Y、R1、R2、R3、R4、R5 和 R6 如本文所述。这些化合物可用作抗肿瘤药。这些化合物还可用作抗银屑病药物。